Cargando…

Plasma renin activity variation following admission predicts patient outcome in acute decompensated heart failure with reduced and mildly reduced ejection fraction

Plasma renin activity (PRA) level at admission is reported to be a prognostic predictor of acute decompensated heart failure (ADHF) patients. Although PRA is affected during hospitalization by several factors including fluid volume and drug titration, whether the changes in PRA levels during hospita...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azuma, Kohei, Nishimura, Koichi, Min, Kyung-Duk, Takahashi, Kanae, Matsumoto, Yuki, Eguchi, Akiyo, Okuhara, Yoshitaka, Naito, Yoshiro, Suna, Sinichiro, Asakura, Masanori, Ishihara, Masaharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898650/ https://www.ncbi.nlm.nih.gov/pubmed/36747544 http://dx.doi.org/10.1016/j.heliyon.2023.e13181

Ejemplares similares

Effects of early diuretic response to carperitide in acute decompensated heart failure treatment: A single-center retrospective study
por: Okuhara, Yoshitaka, et al.
Publicado: (2018)

Reduction in Left Ventricular Ejection Fraction is Associated with Subsequent Cardiac Events in Outpatients with Chronic Heart Failure
por: Okuhara, Yoshitaka, et al.
Publicado: (2019)

Temporary Dietary Iron Restriction Affects the Process of Thrombus Resolution in a Rat Model of Deep Vein Thrombosis
por: Oboshi, Makiko, et al.
Publicado: (2015)

Haploinsufficiency of Transferrin Receptor 1 Impairs Angiogenesis with Reduced Mitochondrial Complex I in Mice with Limb Ischemia
por: Okuno, Keisuke, et al.
Publicado: (2019)

Reduced lifespan of erythrocytes in Dahl/Salt sensitive rats is the cause of the renal proximal tubule damage
por: Manabe, Eri, et al.
Publicado: (2020)

Clinical utility of reticulocyte hemoglobin equivalent in patients with heart failure
por: Tahara, Saki, et al.
Publicado: (2022)

Anemia has an impact on prognosis in heart failure with preserved ejection fraction with mild chronic kidney disease
por: Okuno, Keisuke, et al.
Publicado: (2021)

Real‐world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction
por: Oh, Jaewon, et al.
Publicado: (2022)

ACUTE MYOCARDITIS AND ACUTE DECOMPENSATED HEART FAILURE WITH REDUCED EJECTION FRACTION IN COVID-19
por: Choudhary, Khushal, et al.
Publicado: (2021)

Increased Renal Iron Accumulation in Hypertensive Nephropathy of Salt-Loaded Hypertensive Rats
por: Naito, Yoshiro, et al.
Publicado: (2013)

The prognostic value of heart rate at discharge in acute decompensation of heart failure with reduced ejection fraction
por: Bahouth, Fadel, et al.
Publicado: (2021)

Plasma renin activity in patients with heart failure and reduced ejection fraction on optimal medical therapy
por: Nijst, Petra, et al.
Publicado: (2017)

Consensus and development of document for management of stabilized acute decompensated heart failure with reduced ejection fraction in India
por: Kaul, U., et al.
Publicado: (2020)

Sacubitril/valsartan reduces cardiac decompensation in heart failure with preserved ejection fraction: a meta-analysis
por: Basile, Christian, et al.
Publicado: (2023)

Use of Renin–Angiotensin–Aldosterone System Inhibitors in Older Patients with Heart Failure and Reduced Ejection Fraction
por: Stolfo, Davide, et al.
Publicado: (2019)

Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction
por: Rosano, Giuseppe MC, et al.
Publicado: (2019)

Optimal Heart Rate Control Improves Long-Term Prognosis of Decompensated Heart Failure with Reduced Ejection Fraction
por: Tsai, Ming-Lung, et al.
Publicado: (2023)

Urgent Control of Rapid Atrial Fibrillation by Landiolol in Patients With Acute Decompensated Heart Failure With Severely Reduced Ejection Fraction
por: Iwahashi, Noriaki, et al.
Publicado: (2019)

Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction
por: Ibrahim, Ayman, et al.
Publicado: (2020)

Successful treatment with ivabradine in a β‐blocker‐refractory patient with acute decompensated heart failure with reduced ejection fraction
por: Inoue, Tomoko, et al.
Publicado: (2023)

Clinical and Imaging Parameters Associated With Impaired Kidney Function in Patients With Acute Decompensated Heart Failure With Reduced Ejection Fraction
por: Cho, In-Jeong, et al.
Publicado: (2023)

Relationship between intrarenal renin-angiotensin activity and re-hospitalization in patients with heart failure with reduced ejection fraction
por: Örsçelik, Özcan, et al.
Publicado: (2018)

Clinical outcomes of levosimendan versus dobutamine in patients with acute decompensated heart failure with reduced ejection fraction and impaired renal function
por: John, Basil, et al.
Publicado: (2021)

Role of renin–angiotensin system antagonists on long-term mortality post-percutaneous coronary intervention in reduced and preserved ejection fraction
por: Prosser, Hamish C., et al.
Publicado: (2022)

Impact of the Geriatric Nutritional Risk Index on In-Hospital Mortality and Length of Hospitalization in Patients with Acute Decompensated Heart Failure with Preserved or Reduced Ejection Fraction
por: Hirose, Susumu, et al.
Publicado: (2020)

Sacubitril/Valsartan Initiation Among Veterans Who Are Renin‐Angiotensin‐Aldosterone System Inhibitor Naïve With Heart Failure and Reduced Ejection Fraction
por: Mohanty, April F., et al.
Publicado: (2021)

Crosstalk between Iron and Arteriosclerosis
por: Naito, Yoshiro, et al.
Publicado: (2022)

Effects of renin–angiotensin inhibitors on renal function and the clinical course in patients with decompensated cirrhosis
por: Tergast, Tammo L., et al.
Publicado: (2023)

The serum angiotensin-converting enzyme 2 and angiotensin-(1-7) concentrations after optimal therapy for acute decompensated heart failure with reduced ejection fraction
por: Hisatake, Shinji, et al.
Publicado: (2020)

Implications of renin‐angiotensin‐system blocker discontinuation in acute decompensated heart failure with systolic dysfunction
por: Darden, Douglas, et al.
Publicado: (2019)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

Combined Assessment of D-Dimer with the Get with the Guidelines—Heart Failure Risk Score and N-Terminal Pro-B-Type Natriuretic Peptide in Patients with Acute Decompensated Heart Failure with Preserved and Reduced Ejection Fraction
por: Naruse, Hiroyuki, et al.
Publicado: (2021)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

Vericiguat for Heart Failure with Reduced Ejection Fraction
por: Lombardi, Carlo Mario, et al.
Publicado: (2021)

Management of heart failure with reduced ejection fraction
por: Haydock, Paul M, et al.
Publicado: (2022)

Anesthetic Management Using Remimazolam for Transcatheter Edge-to-Edge Repair of the Mitral Valve in Patients With Reduced Ejection Fraction: A Case Report of Two Cases
por: Ito, Hisakatsu, et al.
Publicado: (2022)

Overexpression of PD‐L1 in gingival basal keratinocytes reduces periodontal inflammation in a ligature‐induced periodontitis model
por: Wongtim, Keeratika, et al.
Publicado: (2021)

Total 25-Hydroxyvitamin D Is an Independent Marker of Left Ventricular Ejection Fraction in Heart Failure with Reduced and Mildly Reduced Ejection Fraction
por: Szabo, Timea Magdolna, et al.
Publicado: (2023)

Renin Activity in Heart Failure with Reduced Systolic Function—New Insights
por: Sullivan, Ryan D., et al.
Publicado: (2019)

Association between class of foundational medication for heart failure and prognosis in heart failure with reduced/mildly reduced ejection fraction
por: Ito, Miyuki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fjfb2cghfvl64dmhb5lcc4i74h